Company / Cash per Share
TENAX THERAPEUTICS, INC. Cash per Share History
FY2012-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$318.16
FY2024
5-year range
$0.03 / $318.16
FY2020-FY2024
Trend
+112767.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +112768% YoY in FY2024, a notable deviation from the 4-year average annual change of +28387%.
Based on SEC 10-K filings.
318.16 in FY2024 with a 10-year CAGR of +78.4%.
Improved from $0.03 to $318.16 over the past 9 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +78.4%
Key checks
Key Insights
- In FY2024, cash per share increased 112767.8% year-over-year.
- Lowest cash per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $318.16 | +112767.8% |
| FY2016 | $0.28 | +902.2% |
| FY2015 | $0.03 | -97.1% |
| FY2014 | $0.97 | -23.8% |
| FY2013 | $1.28 | - |
| FY2012 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026